Correction to “Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity”

We recently realized that we accidentally duplicated the spleen histologies for the PBS and Podo-NP + CbP-NP + αCD40 groups in Figure S21 on Page S27 of the Supporting Information. We located the correct original histology file for the Podo-NP + CbP-NP + αCD40 group. The corrected Figure S21 is provided in the attached Supporting Information. This correction does not change the conclusions of this paper due to the presence of multiple redundant control groups. We apologize for the error. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.4c14105. Corrected Figure S21 (PDF) Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications.